CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $112 million in its second quarter.
The Cambridge, Massachusetts-based company said it had a loss of $1.93 per share.
The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.74 per share.
The biopharmaceutical company posted revenue of $12.5 million in the period, exceeding Street forecasts. Four analysts surveyed by Zacks expected $9.3 million.
Agios Pharmaceuticals shares have risen 14% since the beginning of the year. The stock has dropped 20% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGIO at https://www.zacks.com/ap/AGIO
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
